Page last updated: 2024-11-07

prednisone and HELLP Syndrome

prednisone has been researched along with HELLP Syndrome in 5 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

HELLP Syndrome: A syndrome of HEMOLYSIS, elevated liver ENZYMES, and low blood platelets count (THROMBOCYTOPENIA). HELLP syndrome is observed in pregnant women with PRE-ECLAMPSIA or ECLAMPSIA who also exhibit LIVER damage and abnormalities in BLOOD COAGULATION.

Research Excerpts

ExcerptRelevanceReference
"During pregnancy the placental 11beta-hydroxysteroid dehydrogenase 2 (11beta-HSD2) enzyme inactivates prednisolone by interconversion into prednisone, protecting the fetus from high levels of prednisolone."9.11The transplacental passage of prednisolone in pregnancies complicated by early-onset HELLP syndrome. ( Bruinse, HW; Franx, A; Huisjes, AJ; Schobben, AF; van Runnard Heimel, PJ, 2005)
"During pregnancy the placental 11beta-hydroxysteroid dehydrogenase 2 (11beta-HSD2) enzyme inactivates prednisolone by interconversion into prednisone, protecting the fetus from high levels of prednisolone."5.11The transplacental passage of prednisolone in pregnancies complicated by early-onset HELLP syndrome. ( Bruinse, HW; Franx, A; Huisjes, AJ; Schobben, AF; van Runnard Heimel, PJ, 2005)
"Acute renal failure is a serious complication of pregnancy associated with a high rate of morbidity and mortality; the incidence is currently 1 per 10,000 pregnancies."2.45[Acute renal failure secondary to hemolytic uremic syndrome in a pregnant woman with pre-eclampsia]. ( Alsina Aser, MJ; García-Miguel, FJ; Mirón Rodríguez, MF, 2009)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Moutos, CP1
Hoyer, P1
Kelly, B1
Saad, AF1
Brucato, A1
Imazio, M1
Curri, S1
Palmieri, G1
Trinchero, R1
García-Miguel, FJ1
Mirón Rodríguez, MF1
Alsina Aser, MJ1
van Runnard Heimel, PJ1
Schobben, AF1
Huisjes, AJ1
Franx, A1
Bruinse, HW1
Elchalal, U1
Gabbay, E1
Nadjari, M1
Varon, D1
Zelig, O1
Ben-Chetrit, E1

Reviews

1 review available for prednisone and HELLP Syndrome

ArticleYear
[Acute renal failure secondary to hemolytic uremic syndrome in a pregnant woman with pre-eclampsia].
    Revista espanola de anestesiologia y reanimacion, 2009, Volume: 56, Issue:2

    Topics: Acute Kidney Injury; Adult; Antihypertensive Agents; Biomarkers; Combined Modality Therapy; Diagnosi

2009

Trials

1 trial available for prednisone and HELLP Syndrome

ArticleYear
The transplacental passage of prednisolone in pregnancies complicated by early-onset HELLP syndrome.
    Placenta, 2005, Volume: 26, Issue:10

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Anti-Inflammatory Agents; Female; Fetus; HELLP Syndrome

2005

Other Studies

3 other studies available for prednisone and HELLP Syndrome

ArticleYear
Pyoderma gangrenosum after cesarean delivery.
    American journal of obstetrics and gynecology, 2021, Volume: 225, Issue:4

    Topics: Anti-Bacterial Agents; Biopsy; Cesarean Section; Cyclosporine; Debridement; Diagnosis, Differential;

2021
Medical treatment of pericarditis during pregnancy.
    International journal of cardiology, 2010, Oct-29, Volume: 144, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Therapy, Combination; Female; Glucocor

2010
Catastrophic antiphospholipid syndrome in the second trimester of pregnancy.
    The Israel Medical Association journal : IMAJ, 2006, Volume: 8, Issue:12

    Topics: Abortion, Induced; Adult; Anti-Inflammatory Agents; Anticoagulants; Antineoplastic Agents, Hormonal;

2006